ONCO vs REGN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

ONCO

36.0
AI Score
VS
REGN Wins

REGN

36.9
AI Score

Investment Advisor Scores

ONCO

36score
Recommendation
SELL

REGN

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ONCO REGN Winner
Revenue 1.81M 13.01B REGN
Net Income -29.25M 3.97B REGN
Net Margin -1614.3% 30.5% REGN
Operating Income -27.34M 3.98B REGN
ROE -86.3% 11.9% REGN
ROA -47.2% 8.9% REGN
Total Assets 61.92M 44.41B REGN
Cash 300,000 3.66B REGN
Current Ratio 0.06 3.35 REGN

Relative Price Performance (Last 90 Days)

ONCO 1M: +577.5% · 3M: +326.1% REGN 1M: +27.4% · 3M: +19.0%

Current Technical Phase

ONCO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (28.3% over 20 days), RSI 63

RSI (14): 63.3 · Price: $3.76

REGN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 70

RSI (14): 70.0 · Price: $959.41

Fundamentals Snapshot

Metric ONCO REGN
Market Cap — —
Forward P/E 0.0 15.4
Trailing P/E 0.0 20.2
Revenue (TTM) — —
Revenue Growth -0.8% 0.4%
Gross Margin 0.8% 0.5%
Operating Margin -11.9% 0.4%
EPS 3103.90 45.24
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, REGN is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.